PREPARATION AND IN VITRO CHARACTERISATION OF ORALLY DISINTEGRATING FILMS CONTAINING NYSTATIN-PEG SOLID DISPERSION FOR THE TREATMENT OF ORAL CANDIDIASIS USING THE ELECTROSPINNING METHOD
11th BBBB International Conference on Pharmaceutical Sciences, Szekszárd, Macaristan, 24 - 26 Eylül 2026, cilt.95, sa.1, ss.13-14, (Özet Bildiri)
- Yayın Türü: Bildiri / Özet Bildiri
- Cilt numarası: 95
- Basıldığı Şehir: Szekszárd
- Basıldığı Ülke: Macaristan
- Sayfa Sayıları: ss.13-14
- Karadeniz Teknik Üniversitesi Adresli: Evet
Özet
Nystatin is a well-known antifungal drug and is classified as Class IV according
to the Biopharmaceutical Classification System (BCS). It is also widely used in
the treatment of oral candidiasis. Although nystatin is insoluble in water and
ethanol, aqueous suspensions or tablet formulations are used in the treatment
of oral candidiasis (1). Nystatin’s low solubility in water may reduce its
efficacy in the treatment of candidiasis (2). To overcome this drawback, orally
disintegrating films (ODFs) containing nystatin have been developed using the
electrospinning method. Eudragit L
100-55, a polymer that dissolves at pH >5.5, was selected because of the pH
of saliva shifts towards acidity (<6.8) in oral candidiasis (3). Nystatin
and Eudragit L 100-55 were dissolved in an ethanol:water (8:2 v/v) mixture, and
films were prepared by electrospinning. However, due to nystatin’s low
solubility, complete dissolution could not be achieved in the electrospinning
solution, and this resulted in the observation of nystatin precipitates on the
fibres in scanning electron microscope (SEM) images. To resolve this issue,
solid dispersions of nystatin with the hydrophilic polymers polyethylene glycol
(PEG) 4000 or PEG 8000 were prepared at various molar ratios. In brief,
nystatin and PEG were dissolved in a methanol:dimethylacetamide (8:2 v/v)
mixture at the specified molar ratios (1:1, 1:3 mol/mol) and dried in an oven
at 30°C. The ODFs of the solid dispersions obtained were prepared using the
same method as the nystatin ODFs. Increasing the proportion of hydrophilic
polymer enhanced the solubility of nystatin and ensured that the active
ingredient was completely encapsulated within the fibres without precipitation.
The carriers used in the preparation of the solid dispersions exhibit non-toxic
properties. Consequently, the prepared nystatin-containing solid dispersion
ODFs did not exhibit any toxic effects on the L929 cell line. However, an
increased anticandidal effect was observed in Candida albicans,
attributed to the improved solubility. Various characterisation studies
conducted on the ODFs (pH, drug loadin, folding endurance, disintegration time
and dissolution rate) also demonstrate that nystatin-containing ODFs with
optimal properties for the treatment of oral candidiasis have been obtained.